Aging and hypertension in kidney function decline: A 10 year population-based study
- PMID: 36277793
- PMCID: PMC9582457
- DOI: 10.3389/fcvm.2022.1035313
Aging and hypertension in kidney function decline: A 10 year population-based study
Abstract
Background: Aging is associated with a physiological decline in kidney function (KFD). In this study, we aimed to describe the impact of age on the rate of KFD and its interplay with risk factors for chronic kidney disease (CKD), considering mainly hypertension (HT), in the general population.
Materials and methods: Participants of European descent, aged 35-75, were recruited from a populational cohort in Lausanne, Switzerland. Participants with a 10 year follow-up were selected. KFD was defined as the difference in estimated glomerular filtration rate (eGFR) between baseline and follow-up, divided by the observation period. Multivariate linear regressions were used with KFD as the outcome and age as the main predictor. HT was tested as a modifying factor.
Results: We included 4,163 participants with mean age 52.2 ± 10.4, 44.7% men, 31.9% HT, and 5.0% diabetics. Mean baseline eGFR was 85.9 ± 14.6 ml/min/1.73 m2. Mean KFD was -0.49 ± 1.08 ml/min/1.73 m2 per year with 70% of participants decreasing their eGFR during follow-up. The relationship between age and KFD was non-linear and age was divided in tertiles. Old participants had faster rates of KFD as compared to young and middle-age participants (p < 0.001). A significant interaction was found between age and HT on KFD prediction (p < 0.001). In HT participants, KFD was significantly different across tertiles of age (p < 0.001). On contrary, KFD was not different across tertiles of age in non-HT participants.
Conclusion: A physiological KFD is present over time in the general population. Age contributes non-linearly to the rate of this decline with older subjects declining the fastest. The presence of HT is a major contributing factor in this setting as KFD worsened with age only in hypertensive participants. Thus, HT represents an important pathological factor aggravating the age-related physiological decline in eGFR in the general population.
Keywords: aging; eGFR; hypertension; kidney function; population.
Copyright © 2022 Jaques, Vollenweider, Bochud and Ponte.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose Study.Ann Med. 2023 Dec;55(1):2216020. doi: 10.1080/07853890.2023.2216020. Ann Med. 2023. PMID: 37272290 Free PMC article.
-
Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease.Ther Clin Risk Manag. 2018 Sep 17;14:1725-1734. doi: 10.2147/TCRM.S167233. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30271157 Free PMC article.
-
Dietary Habits and Risk of Kidney Function Decline in an Urban Population.J Ren Nutr. 2017 Jan;27(1):16-25. doi: 10.1053/j.jrn.2016.08.007. Epub 2016 Oct 19. J Ren Nutr. 2017. PMID: 27771303 Free PMC article.
-
White blood cell count predicts the odds of kidney function decline in a Chinese community-based population.BMC Nephrol. 2017 Jun 7;18(1):190. doi: 10.1186/s12882-017-0608-4. BMC Nephrol. 2017. PMID: 28592280 Free PMC article.
-
Metabolically Healthy Obesity and Risk of Kidney Function Decline.Obesity (Silver Spring). 2018 Apr;26(4):762-768. doi: 10.1002/oby.22134. Epub 2018 Mar 2. Obesity (Silver Spring). 2018. PMID: 29498223 Free PMC article.
Cited by
-
Oxidative balance score predicts chronic kidney disease risk in overweight adults: a NHANES-based machine learning study.Front Nutr. 2025 Jul 16;12:1641496. doi: 10.3389/fnut.2025.1641496. eCollection 2025. Front Nutr. 2025. PMID: 40740644 Free PMC article.
-
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial.Front Immunol. 2025 Mar 13;16:1516146. doi: 10.3389/fimmu.2025.1516146. eCollection 2025. Front Immunol. 2025. PMID: 40248713 Free PMC article. Clinical Trial.
-
Estimating and Predicting the Rate of Kidney Function Decline over 10 Years in the General Population.Kidney360. 2024 Dec 1;5(12):1862-1870. doi: 10.34067/KID.0000000608. Epub 2024 Oct 8. Kidney360. 2024. PMID: 39451006 Free PMC article.
-
Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts.J Clin Med. 2024 Jan 24;13(3):678. doi: 10.3390/jcm13030678. J Clin Med. 2024. PMID: 38337372 Free PMC article. Review.
-
Chronic kidney disease among patients with hypertension in sub-Saharan Africa: a systematic review and meta-analysis.BMC Public Health. 2025 May 1;25(1):1603. doi: 10.1186/s12889-025-22828-8. BMC Public Health. 2025. PMID: 40312329 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous